ISSN: 1309 - 3843 E-ISSN: 1307 - 7384
FİZİKSEL TIP VE REHABİLİTASYON
BİLİMLERİ DERGİSİ
www.jpmrs.com
Kayıtlı İndexler


ORIJINAL ARAŞTIRMA

Kronik Bel Ağrılı Hastalarda Nöropatik Ağrı Skalaları ve Disabilitenin Değerlendirilmesi
The Assessment of the Neuropathic Pain Scales and Disability in Patients with Chronic Low Back Pain Syndrome
Received Date : 19 Aug 2019
Accepted Date : 12 Mar 2020
Available Online : 01 May 2020
Doi: 10.31609/jpmrs.2019-71039 - Makale Dili: EN
J PMR Sci. 2020;23(2):62-8
ÖZET
Amaç: Kronik bel ağrısı, nosiseptif ve nöropatik ağrı oluşum mekanizmalarının bir kombinasyonu ile karakterizedir. Çalışmanın amacı farklı nöropatik ağrı skalalarını kullanarak kronik bel ağrılı hastalarda nöropatik ağrı bileşenini belirlemek ve bel ağrısı ile fiziksel yetersizlik arasındaki ilişkiyi değerlendirmektir. Gereç ve Yöntemler: Çalışma kronik bel ağrılı 102 hasta ile yürütüldü. Hastalar klinik ve demografik olarak değerlendirildi. Nöropatik ağrı komponentleri ve ağrı şiddeti LANSS Ağrı Skalası (The Leeds Assessment of Neuropathic Pain Symptoms and Signs), PainDETECT, DN4 skalası (Douleur Neuropathique 4 Questions) ve 10 cm’lik vizüel analog skala (VAS) ile; fiziksel kısıtlılık İstanbul Bel Ağrısı Disabilite Indeksi ile değerlendirildi. Bulgular: Hastaların yaş ortalaması 44,70±11,98 idi. LANSS kullanıldığında %23,5 hasta, baskın olarak nöropatik ağrı bileşeni gösterdi. Ayrıca nöropatik ağrı sıklığını PAIN-DETECT’te %18,6 ve DN4’te %35,3 olarak bulduk. Tüm nöropatik ağrı skalalarına göre nöropatik ağrının varlığı, İstanbul Bel Ağrısı Disabilite İndeksi skorları ile anlamlı olarak ilişkiliydi (p<0,05). Sonuç: Nosiseptif ağrı, akut bel ağrısında daha belirgin iken, kronik durumlarda nöropatik bileşen daha belirgindir. Kronik bel ağrısının altında yatan mekanizmaları tanımlamak önemlidir. Bel ağrılı hastalarda ağrının kronikliği ve hastalığın ilerlemesi ancak uygun ve erken mekanizma hedefli tedavi yöntemleri ile önlenebilir.
ABSTRACT
Objective: Chronic low back pain (LBP) is characterized by a combination of nociceptive and neuropathic mechanisms of pain generation. We aimed to determine the neuropathic component of LBP and to evaluate its relation with physical disability. Material and Methods: One hundred and two patients with chronic low back pain were included in the study. The patients were evaluated clinically and demographically. Neuropathic pain component and back pain intensity were assessed using the different scales of Leeds Assessment of Neuropathic Signs and Symptoms (LANSS), PAIN/DETECT and DN4 and 10-cm Visual Analog Scale (VAS); Physical disabilities of the patients were also assessed by İstanbul Low Back Pain Disability Index (ILBPDI). Results: The mean age of the patients was 44.70±11.98. When LANSS was used, 23.5% patients demonstrated a predominantly neuropathic pain component. We also found the frequency of neuropathic pain as 18.6% in PAIN/DETECT and 35.3% in DN4. The presence of neuropathic pain according to all neuropathic pain scales was significantly correlated with the scores of ILBPDI (p<0.05). Conclusion: Nociceptive pain is more prominent in acute LBP, whereas neuropathic component is more prominent in chronic conditions. It is important to identify the underlying mechanisms of chronic LBP. Chronicity of pain and disease progression in LBP patients can only be prevented with proper and early mechanisim-targeted treatment methods.
REFERENCES
  1. Krismer M, van Tulder M. Strategies for prevention and management of musculoskeletal conditions. Low back pain (non-specific). Best Pract Res Clin Rheumatol. 2007;21:77-91. [Crossref]  [PubMed] 
  2. McBeth J, Jones K. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol. 2007;21:403-25. [Crossref]  [PubMed] 
  3. Helmhout PH, Staal JB, Heymans MV, et al. Prognostic factors for perceived recovery or functional improvement in non-specific low back pain: secondary analyses of three randomized clinical trials. Eur Spine J. 2010;19:650-9. [Crossref]  [PubMed]  [PMC] 
  4. Chou R, Huffman LH. Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007;147:492-504. [Crossref]  [PubMed] 
  5. Poitras S, Brosseau L. Evidence-informed management of chronic low back pain with transcutaneous electrical nerve stimulation, interferential current, electrical muscle stimulation, ultrasound, and thermotherapy. Spine J. 2008;8:226-33. [Crossref]  [PubMed] 
  6. van Middelkoop M, Rubinstein SM, Kuijpers T, et al. A systematic review on the effectiveness of physical and rehabilitation interventions for chronic non-specific low back pain. Eur Spine J. 2011;20:19-39. [Crossref]  [PubMed]  [PMC] 
  7. van Middelkoop M, Rubinstein SM, Verhagen AP, et al. Exercise therapy for chronic non-specific low-back pain. Best Pract Res Clin Rheumatol. 2010;24:193-204. [Crossref]  [PubMed] 
  8. Freynhagen R, Baron R. The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep. 2009;13:185-90. [Crossref]  [PubMed] 
  9. Van Boxem K, Cheng J, Patijn J, et al. Lumbosacral radicular pain. Pain Pract. 2010;10:339-58. [Crossref]  [PubMed] 
  10. Audette JF, Emenike E, Meleger AL. Neuropathic low back pain. Curr Pain Headache Rep. 2005;9:168-77. [Crossref]  [PubMed] 
  11. Bennet M. The LANSS pain scale: the leeds assessment of neuropathic symptoms and signs. Pain. 2001;92:147-57. [Crossref] 
  12. Freynhagen R, Baron R, Gockel U, et al. PainDETECT: a new screening. Curr Med Res Opin. 2006;22:1911-20. [Crossref]  [PubMed] 
  13. Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114:29-36. [Crossref]  [PubMed] 
  14. Duruöz MT, Özcan E, Ketenci A, et al. Development and validation of a functional disability index for chronic low back pain. J Back Musculoskelet Rehabil. 2013;26:45-54. [Crossref]  [PubMed] 
  15. Backonja M. Defining neuropathic pain. Anesth Analg. 2003;97:785-90. [Crossref]  [PubMed] 
  16. Kaki AM, El-Yaski AZ, Youseif E. Identifying neuropathic pain among patients with chronic low-back pain: use of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale. Reg Anesth Pain Med. 2005;30:422-8. [Crossref] 
  17. Hassan AE, Saleh HA, Baroudy YM, et al. Prevalence of neuropathic pain among patients suffering from chronic low back pain in Saudi Arabia. Saudi Med J. 2004;25:1986-90.
  18. El Sissi W, Arnaout A, Chaarani MW, et al. Prevalence of neuropathic pain among patients with chronic low-back pain in the Arabian gulf region assessed using the leeds assessment of neuropathic symptoms and signs pain scale. J Intern Med Res 2010;38:2135-45. [Crossref]  [PubMed] 
  19. Morsø L, Kent PM, Albert HB. Are self-reported pain characteristics, classified using the painDETECT questionnaire, predictive of outcome in people with low back pain and associated leg pain? Clin J Pain. 2011;27:535-41. [Crossref]  [PubMed] 
  20. Beith ID, Kamp A, Kanyon J, et al. Identifying neuropathic back and leg pain: a cross-sectional study. Pain. 2011;152:1511-6. [Crossref]  [PubMed] 
  21. Walsh J, Rabey MI, Hall TM. Agreement and correlation between the self-report leeds assessment of neuropathic symptoms and signs and Douleur Neuropathique 4 Questions neuropathic pain screening tools in subjects with low back-related leg pain. J Manipulative Physiol Ther. 2012;35:196-202. [Crossref]  [PubMed] 
  22. Haliloğlu S. Kronik bel ağrısının nöropatik komponenti. Yeni Tıp Dergisi. 2013;30:148-51.
  23. Attal N, Perrot S, Fermanian J, et al. The neuropathic components of chronic low back pain: a prospective multicenter study using the DN4 questionnaire. J Pain. 2011;12:1080-7. [Crossref]  [PubMed]